Crysvita

Made by

• Kyowa Kirin

Active Ingredient

Burosumab (genetical recombination)

Prospectus

Approval date

2019/9/20

Treats

• Autosomal dominant hypophosphatemic rickets

Dosages

• CRYSViTA Subcutaneous Injection - 304818円／瓶

• CRYSViTA Subcutaneous Injection - 608282円／瓶

• CRYSViTA Subcutaneous Injection - 911812円／瓶